Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Pak J Pharm Sci ; 28(6): 2161-6, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26639484

RESUMO

In this study, antioxidant activity, total phenolic and flavonoids content of four different fractions from the traditional Korean polyherbal medicine of Modified Bo-yang-Hwan-o-Tang (mBHT) was determined using spectrophotometric methods. Antioxidant activity of fractions was expressed as percentage of DPPH radicals inhibition and IC50 values (µg/ml). Values in percentage ranged from 48.35 to 77.43%. The reducing powers of all the extracts were comparable with that of positive control sample of Butylated hydroxyl tolune (BHT) and ascorbic acid which was found to be dose dependent. Total phenolic content ranged from 106.83 ± 0.002 to 188.661 ± 0.002 mg/g, expressed as gallic acid equivalents. The total flavonoid contents varied from 28.44 ± 0.001 to 105.25 ± 0.001 mg/g, expressed as quarcetin equivalents. Ethyl acetate fractions of mBHT showed the highest phenolic (188.66 mg GAE/g) and flavonoids (105.25 mg QAE/g) contents and strong antioxidant activity. Total phenolics and flavonoid content of all the mBHT fractions were found reasonably correlated with IC50 of DPPH (R²=0.980 and 0.932, respectively). The high contents of phenolic compounds indicated that these compounds responsible for antioxidant activity. Therefore, ethyl acetate fractions of mBHT can be regarded as promising candidates for natural plant sources of antioxidants.


Assuntos
Antioxidantes/análise , Flavonoides/análise , Fenóis/análise , Extratos Vegetais/análise , Acetatos/química , Antioxidantes/química , Compostos de Bifenilo/química , Fracionamento Químico , Flavonoides/química , Fenóis/química , Picratos/química , Extratos Vegetais/química , Solventes/química
2.
Curr Diabetes Rev ; 17(4): 486-495, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33297917

RESUMO

Conventional delivery of antidiabetic drugs faces many problems like poor absorption, low bioavailability, and drug degradation. Nanoemulsion is a unique drug technology, which is very suitable for the delivery of antidiabetic drugs. In recent years, the flaws of delivering anti-hypoglycaemic drugs have been overcome by choosing nanoemulsion drug technology. They are thermodynamically stable and also provide the therapeutic agent for a longer duration. Generally, nanoemulsions are made up of either oil-in-water or water-in-oil and the size of the droplets is from fifty to thousand nanometer. Surfactants are critical substances that are added in the manufacturing of nanoemulsions. Only the surfactants which are approved for human use can be utilized in the manufacturing of nanoemulsions. Generally, the preparation of emulsions includes mixing of the aqueous phase and organic phase and using surfactant with proper agitation. Nanoemulsions are used for antimicrobial drugs, and they are also used in the prophylaxis of cancer. Reduction in the droplet size may cause variation in the elastic and optical behaviour of nanoemulsions.


Assuntos
Sistemas de Liberação de Medicamentos , Hipoglicemiantes , Emulsões , Humanos , Tensoativos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA